AGR2 and biliary tract cancer: In a biliary tract cancer study on the SNU-245 and SNU-478 primary patient cell lines, low levels of AGR2 were correlated with increased disease-free survival (DFS), whereas high levels of AGR2 showed a lower DFS [67,68].